{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:44Z","timestamp":1787004824053,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1053\/j.jvca.2021.04.030","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T18:22:27Z","timestamp":1619374947000},"page":"2651-2658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Use of Factor Eight Inhibitor Bypass Activity (FEIBA) for the Treatment of Perioperative Hemorrhage in Left Ventricular Assist Device Implantation"],"prefix":"10.1053","volume":"35","author":[{"given":"Christian","family":"O'Donnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Madhok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2331-3961","authenticated-orcid":false,"given":"Husham","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2325-8317","authenticated-orcid":false,"given":"Connor G.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hiesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2021.04.030_bib0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12028-017-0386-7","article-title":"Stroke and intracranial hemorrhage in HeartMate II and HeartWare left ventricular assist devices: A systematic review","volume":"27","author":"Cho","year":"2017","journal-title":"Neurocrit Care"},{"key":"10.1053\/j.jvca.2021.04.030_bib0002","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.athoracsur.2014.02.041","article-title":"Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients","volume":"97","author":"Whitson","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2021.04.030_bib0003","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/ejcts\/ezy044","article-title":"Incidence, predictors and clinical outcome of early bleeding events in patients undergoing a left ventricular assist device implant","volume":"54","author":"Muslem","year":"2018","journal-title":"Eur J Cardio-thoracic Surg"},{"issue":"6 Suppl","key":"10.1053\/j.jvca.2021.04.030_bib0004","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0003-4975(03)00478-8","article-title":"Left ventricular assist devices and bleeding: Adding insult to injury","volume":"75","author":"Goldstein","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2021.04.030_bib0005","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.athoracsur.2010.11.007","article-title":"Bleeding complications and blood product utilization with left ventricular assist device implantation","volume":"91","author":"Schaffer","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2021.04.030_bib0006","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1161\/CIRCULATIONAHA.111.040246","article-title":"Bleeding and thrombosis in patients with continuous-flow ventricular assist devices","volume":"125","author":"Eckman","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.04.030_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11886-015-0670-0","article-title":"Coagulopathy in mechanical circulatory support: A fine balance","volume":"17","author":"Rosenthal","year":"2015","journal-title":"Curr Cardiol Rep"},{"key":"10.1053\/j.jvca.2021.04.030_bib0008","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.healun.2016.12.010","article-title":"Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices","volume":"36","author":"Frontera","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2021.04.030_bib0009","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.jacc.2013.05.089","article-title":"Major bleeding during heartmate II support","volume":"62","author":"Bunte","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2021.04.030_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1537-2995.2007.01573.x","article-title":"Perioperative bleeding with cardiac surgery","volume":"48","author":"Despotis","year":"2008","journal-title":"Transfusion"},{"key":"10.1053\/j.jvca.2021.04.030_bib0011","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.athoracsur.2010.11.078","article-title":"Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines","volume":"91","author":"Ferraris","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2021.04.030_bib0012","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00134-004-2388-0","article-title":"Coagulation disorders of cardiopulmonary bypass: A review","volume":"30","author":"Paparella","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2021.04.030_bib0013","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s12265-010-9222-6","article-title":"Hematologic effects of continuous flow left ventricular assist devices","volume":"3","author":"Slaughter","year":"2010","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1053\/j.jvca.2021.04.030_bib0014","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/CIRCULATIONAHA.108.764308","article-title":"Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery","volume":"118","author":"Karkouti","year":"2008","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.04.030_bib0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF03022322","article-title":"The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings of the Canadian Census Conference","volume":"54","author":"Karkouti","year":"2007","journal-title":"Can J Anesth"},{"key":"10.1053\/j.jvca.2021.04.030_bib0016","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.jvca.2011.03.004","article-title":"Recombinant activated factor VII increases stroke in cardiac surgery: A meta-analysis","volume":"25","author":"Ponschab","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2021.04.030_bib0017","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.295.3.293","article-title":"Thromboembolic adverse events after use of recombinant human coagulation factor VIIa","volume":"295","author":"O'Connell","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.jvca.2021.04.030_bib0018","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1213\/01.ane.0000209023.96418.e5","article-title":"Small-dose recombinant activated factor VII (NovoSeven\u00ae) in cardiac surgery","volume":"102","author":"Romagnoli","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2021.04.030_bib0019","first-page":"1314","article-title":"Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery","volume":"40","author":"Chapman","year":"2011","journal-title":"Eur J Cardiothoracic Surg"},{"key":"10.1053\/j.jvca.2021.04.030_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1537-2995.2005.04216.x","article-title":"Recombinant factor VIIa for intractable blood loss after cardiac surgery: A propensity score-matched case-control analysis","volume":"45","author":"Karkouti","year":"2005","journal-title":"Transfusion"},{"key":"10.1053\/j.jvca.2021.04.030_bib0021","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1097\/01.CCM.0000181527.47749.57","article-title":"Recombinant activated factor VII for refractory bleeding after cardiac surgery \u2013 A retrospective analysis of safety and efficacy","volume":"33","author":"Von Heymann","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2021.04.030_bib0022","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jtcvs.2013.11.020","article-title":"Safety and efficacy of prothrombin complex concentrates for the treatment of coagulopathy after cardiac surgery","volume":"147","author":"Song","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2021.04.030_bib0023","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood.V61.1.36.36","article-title":"The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors","volume":"61","author":"Hilgartner","year":"1983","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2021.04.030_bib0024","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1056\/NEJMoa1104435","article-title":"Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors","volume":"365","author":"Leissinger","year":"2011","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.1053\/j.jvca.2021.04.030_bib0025","first-page":"3","article-title":"FEIBA \u00d2\u202f: mode of action","volume":"10","author":"Gritsch","year":"2004","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2021.04.030_bib0026","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/hae.12873","article-title":"Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA\u00ae in prophylactic therapy","volume":"22","author":"Varadi","year":"2016","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2021.04.030_bib0027","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1053\/j.jvca.2014.04.015","article-title":"Factor VIII inhibitor bypass activity and recombinant activated factor vii in cardiac surgery","volume":"28","author":"Rao","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2021.04.030_bib0028","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1540-8191.2008.00686.x","article-title":"Factor eight inhibitor bypassing activity (FEIBA) for refractory bleeding in cardiac surgery: Review of clinical outcomes","volume":"23","author":"Balsam","year":"2008","journal-title":"J Card Surg"},{"key":"10.1053\/j.jvca.2021.04.030_bib0029","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1365-2516.2002.00532.x","article-title":"Safety of factor VIII inhibitor bypass activity (FEIBA\u00ae): 10-year compilation of thrombotic adverse events","volume":"8","author":"Ehrlich","year":"2002","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2021.04.030_bib0030","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1538-7836.2005.01201.x","article-title":"Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity \u2013 A rebuttal","volume":"3","author":"Makris","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2021.04.030_bib0031","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12028-015-0213-y","article-title":"The role of FEIBA in reversing novel oral anticoagulants in intracerebral hemorrhage","volume":"24","author":"Dibu","year":"2016","journal-title":"Neurocrit Care"},{"key":"10.1053\/j.jvca.2021.04.030_bib0032","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12028-017-0383-x","article-title":"Safety and effectiveness of Factor VIII inhibitor Bypassing Activity (FEIBA) and fresh frozen plasma in oral anticoagulant-associated intracranial hemorrhage: A retrospective analysis","volume":"27","author":"Yin","year":"2017","journal-title":"Neurocrit Care"},{"key":"10.1053\/j.jvca.2021.04.030_bib0033","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ajem.2018.05.023","article-title":"Safety and effectiveness of Factor Eight Inhibitor Bypassing Activity for direct oral anticoagulant-related hemorrhage reversal","volume":"37","author":"Engelbart","year":"2019","journal-title":"Am J Emerg Med"},{"key":"10.1053\/j.jvca.2021.04.030_bib0034","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11239-018-1680-8","article-title":"Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices","volume":"46","author":"Rimsans","year":"2018","journal-title":"J Thromb Thrombolysis"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021003566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021003566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:52:49Z","timestamp":1760946769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077021003566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1053077021003566"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2021.04.030","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Factor Eight Inhibitor Bypass Activity (FEIBA) for the Treatment of Perioperative Hemorrhage in Left Ventricular Assist Device Implantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2021.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}